Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Department of Defense
Grant: W911QY20C0077
HVTN Statistics and Data Management Center
Grant: UM1 AI68635
HVTN Laboratory Center
Grant: UM1 AI68618
HIV Prevention Trials Network Leadership and Operations Center
Grant: UM1 AI68619
AIDS Clinical Trials Group Leadership and Operations Center
Grant: UM1 AI68636
Infectious Diseases Clinical Research Consortium leadership group
Grant: UM1 AI148684
NIAID NIH HHS
Grant: UM1 AI068619
NIAID NIH HHS
Grant: UM1 AI068635
NIAID NIH HHS
Grant: UM1 AI068618
NIAID NIH HHS
Grant: UM1 AI068636
NIAID NIH HHS
Grant: UM1 AI148689
Medical CBRN
NCI NIH HHS
NIH HHS
National Institute of Allergy and Infectious Diseases
National Cancer Institute
Novavax
Biomedical Advanced Research and Development Authority
National Institutes of Health
Medical CBRN
National Institute of Allergy and Infectious Diseases
Biomedical Advanced Research and Development Authority
Novavax
NCI NIH HHS
NIH HHS
FWCI
3.06
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals